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Maternal Biomarkers of Endothelial Dysfunction and
Preterm Delivery
Xinhua Chen*, Theresa O. Scholl
Department of Obstetrics and Gynecology, Rowan University – School of Osteopathic Medicine, Stratford, New Jersey, United States of America
Abstract
Background: Endothelial dysfunction is key to the development of atherosclerosis. Preterm delivery foreshadows later
maternal cardiovascular disease (CVD), but it is not known if endothelial dysfunction also occurs. We prospectively
measured circulating biomarkers of endothelial dysfunction in pregnant women with preterm or term delivery.
Methods: We conducted a case-control study nested within a large prospective epidemiological study of young, generally
healthy pregnant women. Women who delivered preterm (,37 completed weeks gestation, n = 240) and controls who
delivered at term (n = 439) were included. Pregnancies complicated by preeclampsia were analyzed separately. Circulating
endothelial dysfunction biomarkers included soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion
molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin).
Results: Elevated levels of sICAM-1 and sVCAM-1 were positively associated with preterm delivery independent of usual risk
factors. At entry (,16 wks), the adjusted odds ratio (AOR) was 1.73 (95% confidence interval (CI) 1.09–2.74) for the highest
quartile of sICAM-1 versus the lowest quartile and for sVCAM-1 the AOR was 2.17 (95% CI 1.36–3.46). When analysis was
limited to cases with a spontaneous preterm delivery, the results were unchanged. Similar results were obtained for the 3rd
trimester (,30 wks). Elevated sE-selectin was increased only in preterm delivery complicated by preeclampsia; risk was
increased at entry (AOR 2.32, 95% CI 1.22–4.40) and in the 3rd trimester (AOR 3.37, 95% CI 1.78–6.39).
Conclusions: Impaired endothelial function as indicated by increased levels of soluble molecules commonly secreted by
endothelial cells is a pathogenic precursor to CVD that is also present in women with preterm delivery. Our findings
underscore the need for follow-up studies to determine if improving endothelial function prevents later CVD risk in women.
Citation: Chen X, Scholl TO (2014) Maternal Biomarkers of Endothelial Dysfunction and Preterm Delivery. PLoS ONE 9(1): e85716. doi:10.1371/
journal.pone.0085716
Editor: Marta Letizia Hribal, University of Catanzaro Magna Graecia, Italy
Received July 19, 2013; Accepted November 30, 2013; Published January 22, 2014
Copyright:  2014 Chen, Scholl. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by research grants from the National Institute of Child Health and Human Development (HD061763 to Chen; HD18269 and
HD38329 to Scholl) and the National Institute on Minority Health and Health Disparities (1R01MD007828 to Chen). The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: chenx1@rowan.edu
Introduction
Pregnancy may be a prognostic state unique to women that
allows early identification and remediation of risk factors and
ultimately the prevention of chronic diseases of later life [1,2].
Serious complications (e.g. gestational diabetes) that signal a
positive ‘stress test’ may also be markers for increased risk (e.g.
type 2 diabetes) later on [3]. Cardiovascular disease (CVD) is a
leading cause of death for women in the United States and CVD
mortality is higher in US women than men [4]. Pregnancy
complications, particularly preeclampsia, may presage susceptibil-
ity to later CVD [5,6]. Preterm delivery, defined as birth occurring
prior to 37 completed weeks’ gestation, is more common than
preeclampsia (2–8%) complicating 12–13% of all births in the
United States [7–9]. Previous epidemiologic data suggest that a
preterm delivery may foreshadow later maternal CVD [10–12].
Vascular endothelial cells are activated under conditions that
occur during pregnancy (inflammation and oxidative stress) and
increase expression of adhesion molecules and selectins [13].
These include the soluble intercellular adhesion molecule-1
(sICAM-1), the vascular cell adhesion molecule-1 (sVCAM-1)
and soluble E-selectin (sE-selectin) [13,14]. Endothelial dysfunc-
tion denotes an imbalance in vascular function. It is considered a
key element in the development of atherosclerosis and associated
with diabetes, insulin resistance, obesity and preeclampsia [14–
17]. While invasive and costly non-invasive methods that directly
measure endothelial function are available, circulating soluble
forms of adhesion molecules and selectins produced by endothelial
cells are widely used as biomarkers of endothelial dysfunction [14–
17].
We hypothesized that endothelial dysfunction is an underlying
pathological state that will manifest in women who deliver preterm
and increase their risk of future CVD. Currently, it is unclear if
these biomarkers are present in pregnant women who deliver
preterm [18]. Thus we examined the association of circulating
sICAM-1, sVCAM-1 and sE-selectin during early and late
pregnancy with preterm delivery. Since preeclampsia is a serious
complication of pregnancy and women with preeclampsia are at
an increased risk for preterm delivery, we also examined
associations in preterm delivery with and without preeclampsia.
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Materials and Methods
Study Design
We conducted a case-control study nested within the Camden
Study, a large prospective epidemiological study of young,
generally healthy pregnant women residing in one of the poorest
cities in the continental United States [19]. The cohort of study
participants enrolled between 1996 and 2006 was recruited from
among patients enrolling at the Osborn Family Health Center,
Our Lady of Lourdes Medical Center and St John the Baptist
prenatal clinic in Camden, NJ. The institutional review board at
the University of Medicine and Dentistry of New Jersey approved
the study protocol. Informed written consent was obtained from
each participant at enrollment (on average at gestational week
13.5664.87, mean 6 SD) after explanation of the nature and
purpose of the study. A total of 3.5% of the women who had
serious non-obstetric problems (e.g. Lupus, type 1 or 2 diabetes,
seizure disorders, malignancies, acute or chronic liver disease, drug
or alcohol abuse and psychiatric problems) were not eligible.
Eighty percent of the patients who were eligible agreed to
participate. A total of 8.3% of participants dropped out after
enrollment due either to a move from the area or to an early
pregnancy loss. A final total of 2,379 participants whose pregnancy
culminated in a live birth were used to select cases and controls.
Data on socioeconomic, demographic and lifestyle were
obtained by interview at entry to care (14.264.01 gestational
weeks, mean 6 SD), and updated at gestational weeks 20 and 28.
Participants were scheduled to see study research assistants before
or after their regular prenatal visits at entry, gestational weeks 20
and 28. Interview data, dietary data and anthropometrics were
collected in person by research assistants at these three times.
Fasting blood samples were drawn at entry (gestational weeks
16.0264.47, mean 6 SD) and during the 3rd trimester (gestational
weeks 30.2863.43). The accepted window for drawing the sample
was +/2 2 weeks. Should the subject not appear, our policy was to
have staff undertake a home visit to obtain the samples. A
standardized protocol for biological specimen collection is used for
the Camden Study which includes the serum preparation used in
the current study. Briefly, whole venous blood was collected into
red topped silicone coated Vacutainer tubes (Becton Dickinson,
Franklin Lakes, NJ), allowed to stay at room temperature for 30–
60 minutes and spun at 15006 g for 10 minutes in a 4uC
centrifuge. The supernatant (serum) was immediately transferred
into clean polypropylene cryovials and stored at 270uC. The
serum samples were aliquoted and not thawed until assayed. The
protocol for samples collected during home visits was the same.
Ethnicity was self-defined. Blood pressure was measured by
clinic staff at each visit and abstracted from the medical records.
BMI (kg/m2) was computed based on self reported pregravid
weight; height was measured at entry to prenatal care. Maternal
obesity was defined as BMI $30.
Definition of Cases and Controls
Preterm delivery is defined as delivery at ,37 completed weeks
of gestation based upon the last menstrual period confirmed or
modified by ultrasound evaluation [8,20]. Detailed information
identifying women with spontaneous preterm delivery, and
medically indicated preterm delivery was obtained from the
prenatal, labor, deliver and newborn records. Information on
reproductive history including prior preterm delivery as well as the
medical events during the current pregnancy was also obtained by
interview and/or abstracted from clinical records.
Preeclampsia is a common condition (,8%) associated with
medically indicated preterm delivery and identified by systolic
blood pressure $140 mmHg or diastolic blood pressure $90 mm
Hg after 20 weeks’ gestation in a previously normotensive woman
accompanied by new-onset proteinuria (.300 mg/24-hour from a
24-hour urine collection or $1+ protein by dipstick in two samples
at least 4-hour apart) [21].
The cases of preterm delivery included all women who delivered
preterm (n = 240) from the underlying cohort. Spontaneous
preterm delivery was defined by the presence of intact membranes,
regular contractions and the absence of induction of labor or an
elective caesarean section. Preterm premature rupture of mem-
brane (PROM) was defined as rupture of membranes before the
onset of labor. Women with spontaneous labor and PROM
leading to preterm delivery were combined into the spontaneous
preterm group (n = 192). The primary reasons for medically
indicated preterm delivery (n = 48) were gestational hypertensive
disorders (n = 23), intrauterine growth restriction (IUGR) (n = 4),
chorionmnionitis (n = 4), fetal distress (n = 4) and others (n = 13).
Normal controls (n = 439) were randomly selected among women
who delivered a term infant by SAS PROC SURVEYSELECT to
assure that distribution of maternal characteristics was the same in
cases and controls.
Analytic Procedures
Serum concentrations of endothelial dysfunction biomarkers
including sICAM-1, sVCAM-1 and sE-selectin were measured by
commercial enzyme-linked immunosorbent assay (ELISA) (R & D
Systems, Minneapolis, Minn). All samples were analyzed in
duplicate. The sensitivity for the assays was 0.096 ng/ml,
0.6 ng/ml and 0.009 ng/ml for sICAM-1, sVCAM-1 and sE-
selectin respectively. The within and between assay coefficient of
variation (%) were 4.3/8.6 for sICAM-1, 4.7/5.9 for sVCAM-1,
3.6/8.2 for sE-selectin.
Statistical Analysis
Maternal characteristics between cases and controls were
compared by Student’s t tests (for continuous variables) and x2
tests (for categorical variables). Analysis of variance was used to
assess the significance of linear trend and compare mean levels of
each endothelial dysfunction biomarker between cases and
controls after controlling for potential confounding variables.
Multiple logistic regression was used to estimate the Odds Ratio
(OR) and 95% confidence interval (CIs) for elevated levels of each
biomarker with preterm delivery. We divided each biomarker into
quartiles and used logistic regression to estimate the OR of
preterm delivery in each quartile using the lowest quartile as the
reference category. Multiple polytomous logistic regression was
used to estimate the association of elevated sE-selectin with
preterm delivery with and without preeclampsia. This is an
extension of traditional logistic regression which models multiple
levels of an outcome so that all adjusted odds ratios are estimated
in the same model. We also analyzed data with pregnancy
complications (gestational diabetes mellitus (GDM) and pre-
eclampsia) that impact endothelial function included or excluded.
We used separate models to examine endothelial dysfunction
biomarkers in preterm delivery at entry and in the 3rd trimester.
Models were controlled for potential confounding variables
including maternal BMI, age, parity, cigarette smoking, and
ethnicity. Potential confounders were defined as those which
altered the adjusted odds ratio or regression coefficient by at least
10%, and assessed by comparing crude and adjusted coefficients.
Prior history of preterm delivery, a known risk factor for preterm
birth, was adjusted in analysis when appropriate. The statistical
significant level was defined as p ,0.05. All statistical analyses
were performed using SAS v.9.1 (SAS Institute, Inc., Cary, NC).
Endothelial Dysfunction and Preterm Delivery
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Results
Maternal characteristics including age, BMI, parity, cigarette
smoking, ethnicity, gestational age and blood pressure at entry
were not significantly different between cases and controls (table 1).
As expected, cases of preterm delivery had significantly shorter
gestations (p,0.0001), infants with lower birth weights (p,
0.0001); more of the cases had a prior history of preterm delivery
(p,0.001) and more were complicated by preeclampsia (p,
0.0001) or had increased 3rd trimester blood pressure (p,0.0001)
compared to controls. No significant difference in gestational
diabetes prevalence was observed between cases and controls
(p = 0.245).
The correlations between concentrations at entry and the 3rd
trimester were 0.68, 0.60, 0.75 for sICAM-1, sVCAM-1 and sE-
selectin respectively (p,0.0001 for each). Mean levels of fasting
serum sICAM-1 and sVCAM-1 were significantly higher in all
cases of preterm delivery and for cases with a spontaneous preterm
delivery (n = 192) at entry (p,0.05 – p,0.001 for each) and in the
3rd trimester (p,0.05 – p,0.001 for each). Concentrations of
serum sE-selectin were not different between cases and controls in
either early or later gestation (p.0.05 for each) (table 2). Although
the concentrations of all three biomarkers were slightly increased
during the 3rd trimester compared to entry, none of the difference
reached statistical significance in the cases or in the controls (p.
0.05 for each). We also observed that the biomarker concentra-
tions were increased in medically indicated preterm delivery
compared to controls (p,0.05 for each). Differences did not reach
statistical significance compared to spontaneous preterm cases
except for sICAM-1 and sE-selectin in the 3rd trimester (p,0.04
for each, table 2).
Elevated levels (highest quartile) of sICAM-1 and sVCAM-1
were positively associated with preterm delivery (p for trend ,0.05
– ,0.001 for each). At entry, the adjusted odds ratio (AOR) was
1.73 (95% CI 1.09–2.74) (table 3, model 1) for the highest quartile
of sICAM-1 relative to the lowest quartile; and for sVCAM-1 the
AOR was 2.17 (95% CI 1.36–3.46). When analyses were limited
to cases with a spontaneous preterm delivery, these results again
remained unchanged (table 3, model 2). We obtained similar data
for the 3rd trimester (table 4). However, sE-selectin was not related
to preterm delivery in either early or later gestation (tables 3 and
4).
We performed additional analyses to confirm that the results
were not driven by preeclampsia and/or GDM (table 5).
Information on a prior history of preterm delivery was added to
the covariates used in tables 3 and 4. Results were consistent when
Table 1. Clinical characteristics of preterm delivery cases and controls*.
Variable Cases Controls p-value
n = 240 n = 439
Entry to care
Age (yr) 22.8265.93 22.1065.20 0.23
BMI (kg/m2) 26.2566.42 25.5965.72 0.43
Obesity (BMI $30) n (%) 57 (23.75) 81 (18.45) 0.11
Nulliparas n (%) 86 (35.83) 175 (39.86) 0.30
Cigarette smoking n (%) 55 (22.92) 83 (18.91) 0.21
Ethnicity n (%)
Hispanic 105 (43.75) 212 (48.29)
African American 100 (41.67) 149 (33.94)
Caucasian and other 35 (14.58) 78 (17.77) 0.13
Medicaid n (%) 238 (99.16) 427 (97.27) 0.24
Gestational age at entry (weeks) 14.1064.80 14.2164.91 0.79
Prior history of preterm delivery n (%){ 37 (24.03) 27 (10.23) 0.0002
Blood pressure
Systolic blood pressure 112.90613.60 111.80611.5 0.20
Diastolic blood pressure 70.1269.70 69.9868.70 0.93
3rd trimester and birth outcome
Blood pressure
Systolic blood pressure 119.83615,41 115.50610.93 ,0.001
Diastolic blood pressure 76.43612.90 72.2069.02 ,0.001
Singleton n (%) 228 (95.00) 438 (99.77) ,0.001
Gestational diabetes mellitus n (%) 14 (5.83) 38 (8.65) 0.249
Preeclampsia n (%) 47 (19.58) 39 (8.88) ,0.0001
Gestational age at delivery (weeks) 33.1463.91 39.2461.21 ,0.0001
Infant birth weight (g) 21786825 33306435 ,0.0001
*Data are mean 6 SD or n (%). p-values are from ANOVA or chi-square test.
{Prior history of preterm delivery in parous women.
doi:10.1371/journal.pone.0085716.t001
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Table 2. Serum concentrations of endothelial dysfunction biomarkers in preterm delivery cases and controls (ng/ml)*.




preterm (n = 192)
Medically Indicated
preterm (n = 48) (n = 439)
Entry to care
sICAM-1 217.0564.63 215.5065.15 227.33610.70 203.2963.40 0.018 0.037 0.026
sVCAM-1 550.9668.34 551.9469.06 551.40619.60 512.9966.13 0.0003 0.0006 0.056
sE-selectin 41.4860.94 40.6861.05 44.8762.13 40.2260.69 0.27 0.62 0.047
3rd trimester
sICAM-1 227.8865.81 222.2066.52 249.85612.56I 206.5463.76 0.0025 0.043 0.001
sVCAM-1 567.22610.63 558.93611.66 595.83623.32 522.6866.84 0.0005 0.0054 0.003
sE-selectin 43.1461.09 41.9361.23 47.2862.40I 41.8560.71 0.33 0.82 0.033
Abbreviations: sICAM-1, soluble intercellular adhesion molecule-1; sVCAM-1, soluble vascular cell adhesion molecule-1; sE-selectin, soluble E-selectin; same as in
tables 3–6.
*Data are mean 6 SE and adjusted for age, BMI, parity, ethnicity and cigarette smoking.
{All preterm delivery cases vs. controls.
`Spontaneous preterm delivery cases vs. controls.
1Medically indicated preterm delivery cases vs. controls.
IMedically indicated preterm delivery cases vs. spontaneous preterm delivery cases p,0.05.
doi:10.1371/journal.pone.0085716.t002
Table 3. Association of elevated endothelial dysfunction biomarkers levels with preterm delivery – Entry to care.
Biomarker Quartile 1 Quartile 2 Quartile 3 Quartile 4
p for
trend
n 169 171 169 170
sICAM-1
Median (IQR), ng/ml 113.4 (31.6–161.1) 189.5 (161.4–208.1) 229.4 (208.3–252.6) 288.7 (252.7–629.3)
Model 1*
OR (95% CI) 1.00 0.98 (0.63–1.55) 1.11 (0.71–1.75) 1.65 (1.06–2.58) 0.022
AOR (95% CI) * 1.00 1.13 (0.70–1.81) 1.23 (0.77–1.95) 1.73 (1.09–2.74) 0.020
Model 2 {
OR (95% CI) 1.00 0.90 (0.55–1.48) 1.04 (0.64–1.69) 1.63 (1.02–2.62) 0.033
AOR (95% CI) 1.00 0.97 (0.58–1.62) 1.07 (0.65–1.76) 1.70 (1.05–2.76) 0.043
sVCAM-1
Median (IQR), ng/ml 402.7 (199.4–443.4) 473.6 (445.3–504.7) 544.1 (505.7–585.0) 661.5 (586.4–1220.6)
Model 1*
OR (95% CI) 1.00 1.03 (0.65–1.64) 1.44 (0.91–2.26) 1.85 (1.18–2.90) 0.002
AOR (95% CI) 1.00 1.07 (0.67–1.72) 1.67 (1.05–2.66) 2.17 (1.36–3.46) 0.0003
Model 2 {
OR (95% CI) 1.00 0.98 (0.59–1.64) 1.53 (0.94–2.49) 1.96 (1.21–3.18) 0.002
AOR (95% CI) 1.00 0.99 (0.59–1.68) 1.74 (1.05–2.88) 2.24 (1.35–3.70) 0.0003
sE-selectin
Median(IQR), ng/ml 23.7 (1.7–29.2) 35.8 (29.2–40.2) 44.9 (40.2–49.4) 58.5 (49.5–92.5)
Model 1*
OR (95% CI) 1.00 1.00 (0.64–1.56) 0.76 (0.48–1.20) 1.27 (0.82–1.97) 0.52
AOR (95% CI) 1.00 0.99 (0.63–1.56) 0.75 (0.47–1.20) 1.22 (0.78–1.92) 0.64
Model 2 {
OR (95% CI) 1.00 0.82 (0.51–1.32) 0.66 (0.41–1.07) 1.02 (0.64–1.63) 0.53
AOR (95% CI) 1.00 0.83 (0.51–1.34) 0.67 (0.41–1.09) 1.00 (0.62–1.61) 0.66
Abbreviations: IQR, interquartile range; OR, unadjusted odds ratio; AOR, adjusted odds ratio; 95% CI, 95% confidence interval.
*Model 1: All preterm cases and controls and was adjusted for age, BMI, ethnicity, parity and cigarette smoking.
{Model 2: Spontaneous preterm cases and controls with same adjustment.
doi:10.1371/journal.pone.0085716.t003
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Table 4. Association of elevated endothelial dysfunction biomarkers levels with preterm delivery: 3rd trimester.
Biomarker Quartile 1 Quartile 2 Quartile 3 Quartile 4 p for trend
n 160 160 160 161
sICAM-1
Median (IQR), ng/ml 120.2 (21.4–168.7) 192.7 (169.1–210.4) 228.0 (210.9–251.7) 282.2 (252.0–953.7)
Model 1*
OR (95% CI) 1.00 0.85 (0.51–1.41) 1.13 (0.69–1.85) 1.95 (1.22–3.13) 0.002
AOR (95% CI) * 1.00 0.94 (0.56–1.59) 1.27 (0.76–2.11) 2.17 (1.32–3.55) 0.001
Model 2 {
OR (95% CI) 1.00 0.85 (0.49–1.47) 0.92 (0.53–1.59) 1.81 (1.09–3.01) 0.019
AOR (95% CI) 1.00 0.90 (0.51–1.57) 0.95 (0.54–1.67) 1.84 (1.08–3.13) 0.022
sVCAM-1
Median (IQR), ng/ml 401.3 (134.3–438.3) 470.4 (439.0–512.6) 547.4 (512.8–595.7) 674.0 (597.0–1136.4)
Model 1*
OR (95% CI) 1.00 1.06 (0.64–1.78) 1.41 (0.86–2.33) 2.32 (1.43–3.76) 0.003
AOR (95% CI) 1.00 1.07 (0.63–1.81) 1.52 (0.92–2.54) 2.55 (1.55–4.19) ,0.0001
Model 2 {
OR (95% CI) 1.00 1.07 (0.62–1.86) 1.23 (0.71–2.13) 2.01 (1.19–3.40) 0.008
AOR (95% CI) 1.00 1.06 (0.61–1.87) 1.29 (0.74–2.25) 2.15 (1.25–3.68) 0.004
sE-selectin
Median(IQR), ng/ml 24.7 (5.3–31.1) 36.6 (31.2–41.1) 46.0 (41.2–52.2) 60.9 (52.3–95.3)
Model 1*
OR (95% CI) 1.00 1.10 (0.67–1.79) 0.90 (0.55–1.48) 1.50 (0.94–2.42) 0.166
AOR (95% CI) 1.00 1.15 (0.70–1.88) 0.89 (0.54–1.47) 1.52 (0.94–2.46) 0.18
Model 2 {
OR (95% CI) 1.00 0.92 (0.55–1.56) 0.77 (0.45–1.32) 1.11 (0.66–1.86) 0.88
AOR (95% CI) 1.00 0.96 (0.57–1.63) 0.77 (0.45–1.32) 1.15 (0.68–1.95) 0.82
Abbreviations: IQR, interquartile range; OR, unadjusted odds ratio; AOR, adjusted odds ratio; 95% CI, 95% confidence interval. Thirty eight patient’s samples or covariates
were not available at the 3rd trimester including 33 cases and 5 controls.
*Model 1: All preterm cases and controls and was adjusted for age, BMI, ethnicity, parity and cigarette smoking.
{Model 2: Spontaneous preterm cases and controls with same adjustment.
doi:10.1371/journal.pone.0085716.t004
Table 5. Elevated sICAM-1 and sVCAM-1 levels and preterm delivery: after inclusion and exclusion of preeclampsia, gestational
diabetes and twins
Entry AOR (95% CI) 3rd trimesterAOR (95% CI)
sICAM-1* sVCAM-1* sICAM-1* sVCAM-1*
All preterm cases vs. controls Model 1 { 1.71 (1.05–2.80) 1.64 (1.00–2.71) 2.10 (1.25–3.50) 1.93 (1.16–3.24)
Model 2 ` 1.70 (1.07–2.72) 2.12 (1.33–3.40) 2.12 (1.29–3.49) 2.44 (1.48–4.03)
Spontaneous preterm cases vs.
controls 1
Model 1 { 1.66 (1.00–2.77) 1.75 (1.03–2.97) 1.85 (1.07–3.20) 1.76 (1.01–3.08)
Model 2 ` 1.66 (1.02–2.71) 2.24 (1.35–3.70) 1.81 (1.06–3.10) 2.01 (1.17–3.47)
Abbreviations: AOR, adjusted odds ratio; 95% CI, 95% confidence interval.
*The AOR (95% CI) compares the highest quartile to the lowest quartile of each biomarker.
{Model 1: Models were adjusted for age, BMI, parity, cigarette smoking, ethnicity, prior history of preterm delivery, preeclampsia and gestational diabetes. Twins were
excluded.
`Model 2. Models were adjusted for age, BMI, parity, cigarette smoking, ethnicity and prior history of preterm delivery. Patients with preeclampsia, gestational diabetes
as well as twins were excluded.
1Medically indicated cases of preterm delivery were excluded.
doi:10.1371/journal.pone.0085716.t005
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preeclampsia and GDM were controlled (table 5, model 1) or
excluded (table 5, model 2) at entry and the 3rd trimester.
We separated preterm deliveries into those with and those
without preeclampsia to determine associations with sE-selectin
(table 6). Elevated sE-selectin concentration (the highest quartile
vs. other quartiles pooled) was significantly associated with preterm
delivery complicated with preeclampsia (at entry, AOR 2.32, 95%
CI 1.22–4.40). Similar results were obtained at the 3rd trimester
where the highest quartile of sE-selectin was associated with more
than a 3-fold increased risk of preterm delivery with preeclampsia
(AOR 3.37, 95% CI 1.78–6.39). A similar association was noted
among controls where there was a 2-fold increased risk of
preeclampsia in the 3rd trimester with high sE-selectin
(AOR = 2.05, 95% CI 1.03–4.10) but not at entry (AOR = 1.49,
95% CI 0.70–3.21). Using the same stratification and compari-
sons, elevated sICAM-1 and sVCAM-1 levels were consistently
and significantly associated with preterm delivery without
preeclampsia (table 6). The exception was sVCAM-1. During
the 3rd trimester the highest quartile was associated with preterm
delivery with (AOR 3.34, 95% CI 1.75–6.39) and without
preeclampsia (AOR = 1.73, 95% CI 1.14–2.63).
Discussion
Our purpose was to determine if endothelial dysfunction
biomarkers which are known to be linked to CVD risk were also
detectable in pregnant women who delivered preterm. This
circumstance is analogous to the later risk of type 2 diabetes
experienced by women with gestational diabetes. In our prospec-
tive nested case-control study of generally healthy pregnant
women from Camden, we made three novel and important
observations. Firstly, elevated serum levels of the endothelial
dysfunction biomarkers sICAM-1 and sVCAM-1 were positively
associated with preterm delivery and spontaneous preterm
delivery. These associations were independent of confounding by
the usual risk factors such as cigarette smoking, preeclampsia and
prior history of preterm delivery. Secondly, the associations were
detectable as early as 16 week gestation (at entry to care) and the
effects persisted to the 3rd trimester. Finally, our data showed that
elevated sE-selectin was not associated with all cases of preterm
delivery but only when a preterm (cases) or a term (controls)
delivery was complicated by preeclampsia. Our research thus
suggests that the physiological demands of pregnancy act as a
‘stress test’. Women who fail the test may be predisposed to
pregnancy complications (such as preeclampsia) or adverse
pregnancy outcome (such as preterm delivery). However, failing
the ‘stress test’ may also allow early identification of women with
risk factors for chronic disease of later life. Our data also support
the plausibility that endothelial dysfunction, a precursor to CVD,
may be associated with pathogenic factors related to preterm
delivery and preeclampsia.
The healthy endothelium secretes and expresses a number of
substances that help to maintain vascular wall structure and
vascular homeostasis [13]. Endothelial dysfunction, a shift toward
reduced vasodilatation, pro-inflammation, and increased throm-
bosis, has been observed in atherosclerosis [13,14,16]. While
endothelial function can be directly measured with non-invasive
methods e.g. blood flow-mediated vasodilation [6,13], biomarkers
of endothelial action (cellular, physiological or mediators)
measured in peripheral blood are more feasible to obtain in large
epidemiological studies. Endothelial cells can be activated, thus
increasing the expression of cell surface adhesion molecules, by
multiple factors including pro-inflammatory cytokines, hypercho-
lesterolemia and oxidative stress [15,17,22,23]. The key function
of intercellular adhesion molecules (ICAM-1) is the regulation of
leukocyte migration to the endothelium and leukocyte activation.
The vascular cell adhesion molecule (VCAM-1) functions as a
transmembrane receptor for the vascular endothelial cell mem-
brane and recruits leukocyte to the sites of inflammation [13,14].
Elevated levels of the soluble form of both markers are sign of
endothelial activation, an early indication of atherosclerosis and
Table 6. Elevated endothelial dysfunction biomarker concentrations and preterm delivery with and without preeclampsia*.
Entry to Care 3rd trimester
Highest quartile of
biomarker {n (%) AOR (95% CI) 1
Highest quartile of
biomarker `n (%) AOR (95% CI) I
sE-selectin
Preterm with preeclampsia (n = 47) 19 (41.3) 2.32 (1.22–4.40) 22 (50.01) 3.37 (1.78–6.39)
Preterm without preeclampsia (n = 193) 50 (25.91) 1.20 (0.81–1.78) 36 (24.66) 1.16 (0.75–1.81)
Controls (n = 439) 99 (22.15) 1.00 100 (22.77) 1.00
sICAM-1
Preterm with preeclampsia (n = 47) 10 (21.28) 1.06 (0.50–2.26) 9 (20.45) 1.10 (0.50–2.44)
Preterm without preeclampsia (n = 193) 63 (32.64) 1.66 (1.12–2.44) 57 (38.78) 2.38 (1.57–3.62)
Controls (n = 439) 94 (21.41) 1.00 95 (21.64) 1.00
sVCAM-1
Preterm with preeclampsia (n = 47) 13 (27.66) 1.50 (0.75–2.99) 20 (46.51) 3.34 (1.75–6.39)
Preterm without preeclampsia (n = 193) 61 (31.66) 1.67 (1.14–2.45) 46 (31.29) 1.73 (1.14–2.63)
Controls (n = 439) 95 (21.64) 1.00 94 (21.40) 1.00
Abbreviations: AOR, adjusted odds ratio; 95% CI, 95% confidence interval.
*Models were adjusted for age, BMI, parity, ethnicity and cigarette smoking.
{Highest quartile of sE-selectin ($49.43 ng/ml), sICAM-1 ($252.72 ng/ml) and sVCAM-1 ($585.04 ng/ml) at entry vs. other quartiles pooled for each biomarker.
`Highest quartile of sE-selectin ($52.21 ng/ml), sICAM-1 ($252.30 ng/ml) and sVCAM-1 ($596.29 ng/ml) at 3rd trimester vs. other quartiles pooled for each biomarker.
1p for trend ,0.05.
Ip for trend ,0.01.
doi:10.1371/journal.pone.0085716.t006
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type 2 diabetes mellitus [17]. Prior research supports the
hypothesis that increased inflammation plays a causal role in the
pathogenesis of preterm delivery and that inflammatory cytokines
induce the endothelium to express adhesion molecules [13,24,25].
Previous studies linking endothelial dysfunction to risk of preterm
delivery were limited, often by small sample size and yielded
inconsistent results [26,27]. A recent case-control study reported
that blood endothelial dysfunction biomarkers at week 31 gestation
were not different between women with threatened spontaneous
preterm labor and controls [18].
Several large epidemiologic studies linking birth records to
maternal death certificates showed that women with a history of
preterm delivery were at increased risk of having CVD and
cerebrovascular events like stroke as a cause of death [10–12].
Whether or not women who delivered preterm shared common
risk factors with CVD was unclear. In this study, we found that
elevated levels of sICAM-1 and sVCAM-1 in early and late
gestation were consistently associated with preterm delivery after
adjustment for potential confounding variables (tables 3 and 4).
Similar results were obtained when cases of preeclampsia or of
medically indicated preterm delivery were excluded (table 5). As
far as we are aware, ours is the first study to document this
relationship during pregnancy and suggests that factors that
underlie preterm delivery may also be related to endothelial
dysfunction in reproductive age women.
E-selectin is a member of the selectin family and its expression
occurs in response to cytokines [13,16]. E-selectin may act as a
proinflammatory agent [28]. We did not find an association
between high serum sE-selectin and risk of preterm delivery
(tables 3 and 4). However, when we stratified cases of preterm
delivery into those with and without preeclampsia, the highest
quartile of sE-selectin at entry and during the 3rd trimester was
associated with preterm delivery complicated by preeclampsia
(table 6). During the 3rd trimester, a positive association was also
observed among controls with preeclampsia. Thus, the underlying
mechanism for preterm delivery complicated by preeclampsia
could be a severe inflammatory response [15].
Previous studies noted impaired endothelial function in women
with a history of preeclampsia compared to women with
uncomplicated pregnancies, at a median interval of 3 years
postpartum [15]. The changes included alterations in brachial
artery diameter, and blood flow as well as increased blood levels of
sE-selectin, with no difference in sICAM-1 [15]. There have been
two additional reports of increased maternal plasma sE-selectin
and/or sVCAM-1 [29,30] in pregnant women where the
biomarkers were measured after preeclampsia became overt.
Our data extend these observations and link endothelial dysfunc-
tion before the diagnosis of preeclampsia to increased risk in
women with preterm and term deliveries complicated by
preeclampsia.
There are some limitations to this study. On one hand, our
study population was young and most of the women were from
ethnic minorities; consequently results may not be generalizable to
other populations. On the other hand, African American women
are at markedly increased risk for CVD as well as for preterm
delivery and preeclampsia [31,32]. These ethnic disparities are
unexplained suggesting that unknown risk factors contribute. Thus
our findings may have important implications for the prevention
and treatment of CVD in high risk populations. In addition,
factors such as dysregulation of glucose metabolism and oxidative
stress, both of which impact the biomarkers of endothelial
dysfunction, were not measured in the current study. Finally, it
would be ideal if the cases were more homogeneous and limited to
primiparous women, an issue which can be addressed in future
research.
In summary, our research supports the hypothesis that
endothelial dysfunction (as indicated by the increased concentra-
tion of three substances secreted by the endothelium), a common
pathogenic precursor to CVD is detectable under the stress of
pregnancy in women who deliver preterm (sICAM-1 and
sVCAM-1) or have a preterm delivery complicated by preeclamp-
sia (sE-selectin). Therapeutic interventions such as supplementa-
tion with ascorbic acid, coenzyme Q10 or statins suggest that
endothelial dysfunction may be a modifiable risk factor [15,33,34].
Our findings underscore the importance of follow-up studies to
determine if improving endothelial function may reduce later life
CVD risk in women.
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